MMP9 and atherosclerosis: It is also suggested that CMV can participate in atherosclerosis by inducing vascular endothelial dysfunction and apoptosis, reduced matrix metalloproteinase 9 (MMP9) activity, increased coagulation and thrombosis, elevated release of proatherosclerotic or proinflammatory molecules, increased intimal thickening and lipid deposition (138).